Stay Ahead, Stay ONMINE

How aging clocks can help us understand why we age—and if we can reverse it

Be honest: Have you ever looked up someone from your childhood on social media with the sole intention of seeing how they’ve aged?  One of my colleagues, who shall remain nameless, certainly has. He recently shared a photo of a former classmate. “Can you believe we’re the same age?” he asked, with a hint of glee in his voice. A relative also delights in this pastime. “Wow, she looks like an old woman,” she’ll say when looking at a picture of someone she has known since childhood. The years certainly are kinder to some of us than others. But wrinkles and gray hairs aside, it can be difficult to know how well—or poorly—someone’s body is truly aging, under the hood. A person who develops age-related diseases earlier in life, or has other biological changes associated with aging (such as elevated cholesterol or markers of inflammation), might be considered “biologically older” than a similar-age person who doesn’t have those changes. Some 80-year-olds will be weak and frail, while others are fit and active.  Doctors have long used functional tests that measure their patients’ strength or the distance they can walk, for example, or simply “eyeball” them to guess whether they look fit enough to survive some treatment regimen, says Tamir Chandra, who studies aging at the Mayo Clinic.  But over the past decade, scientists have been uncovering new methods of looking at the hidden ways our bodies are aging. What they’ve found is changing our understanding of aging itself.  “Aging clocks” are new scientific tools that can measure how our organs are wearing out, giving us insight into our mortality and health. They hint at our biological age. While chronological age is simply how many birthdays we’ve had, biological age is meant to reflect something deeper. It measures how our bodies are handling the passing of time and—perhaps—lets us know how much more of it we have left. And while you can’t change your chronological age, you just might be able to influence your biological age. It’s not just scientists who are using these clocks. Longevity influencers like Bryan Johnson often use them to make the case that they are aging backwards. “My telomeres say I’m 10 years old,” Johnson posted on X in April. The Kardashians have tried them too (Khloé was told on TV that her biological age was 12 years below her chronological age). Even my local health-food store offers biological age testing. Some are pushing the use of clocks even further, using them to sell unproven “anti-aging” supplements. The science is still new, and few experts in the field—some of whom affectionately refer to it as “clock world”—would argue that an aging clock can definitively reveal an individual’s biological age.  But their work is revealing that aging clocks can offer so much more than an insta-brag, a snake-oil pitch—or even just an eye-catching number. In fact, they are helping scientists unravel some of the deepest mysteries in biology: Why do we age? How do we age? When does aging begin? What does it even mean to age? Ultimately, and most importantly, they might soon tell us whether we can reverse the whole process. Clocks kick off The way your genes work can change. Molecules called methyl groups can attach to DNA, controlling the way genes make proteins. This process is called methylation, and it can potentially occur at millions of points along the genome. These epigenetic markers, as they are known, can switch genes on or off, or increase or decrease how much protein they make. They’re not part of our DNA, but they influence how it works. In 2011, Steve Horvath, then a biostatistician at the University of California, Los Angeles, took part in a study that was looking for links between sexual orientation and these epigenetic markers. Steve is straight; he says his twin brother, Markus, who also volunteered, is gay. That study didn’t find a link between DNA methyl­ation and sexual orientation. But when Horvath looked at the data, he noticed a different trend—a very strong link between age and methylation at around 88 points on the genome. He once told me he fell off his chair when he saw it.  Many of the affected genes had already been linked to age-related brain and cardiovascular diseases, but it wasn’t clear how methylation might be related to those diseases.  If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all. In 2013, Horvath collected methylation data from 8,000 tissue and cell samples to create what he called the Horvath clock—essentially a mathematical model that could estimate age on the basis of DNA methylation at 353 points on the genome. From a tissue sample, it was able to detect a person’s age within a range of 2.9 years. That clock changed everything. Its publication in 2013 marked the birth of “clock world.” To some, the possibilities were almost endless. If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all. The epigenetic clock was a success story in “a field that, frankly, doesn’t have a lot of success stories,” says João Pedro de Magalhães, who researches aging at the University of Birmingham, UK. It took a few years, but as more aging researchers heard about the clock, they began incorporating it into their research and even developing their own clocks. Horvath became a bit of a celebrity. Scientists started asking for selfies with him at conferences, he says. Some researchers even made T-shirts bearing the front page of his 2013 paper. Some of the many other aging clocks developed since have become notable in their own right. Examples include the PhenoAge clock, which incorporates health data such as blood cell counts and signs of inflammation along with methyl­ation, and the Dunedin Pace of Aging clock, which tells you how quickly or slowly a person is aging rather than pointing to a specific age. Many of the clocks measure methylation, but some look at other variables, such as proteins in blood or certain carbohydrate molecules that attach to such proteins. Today, there are hundreds or even thousands of clocks out there, says Chiara Herzog, who researches aging at King’s College London and is a member of the Biomarkers of Aging Consortium. Everyone has a favorite. Horvath himself favors his GrimAge clock, which was named after the Grim Reaper because it is designed to predict time to death. That clock was trained on data collected from people who were monitored for decades, many of whom died in that period. Horvath won’t use it to tell people when they might die of old age, he stresses, saying that it wouldn’t be ethical. Instead, it can be used to deliver a biological age that hints at how long a person might expect to live. Someone who is 50 but has a GrimAge of 60 can assume that, compared with the average 50-year-old, they might be a bit closer to the end. GrimAge is not perfect. While it can strongly predict time to death given the health trajectory someone is on, no aging clock can predict if someone will start smoking or get a divorce (which generally speeds aging) or suddenly take up running (which can generally slow it). “People are complicated,” Horvath tells MIT Technology Review. “There’s a huge error bar.” On the whole, the clocks are pretty good at making predictions about health and lifespan. They’ve been able to predict that people over the age of 105 have lower biological ages, which tracks given how rare it is for people to make it past that age. A higher epigenetic age has been linked to declining cognitive function and signs of Alzheimer’s disease, while better physical and cognitive fitness has been linked to a lower epigenetic age. Black-box clocks But accuracy is a challenge for all aging clocks. Part of the problem lies in how they were designed. Most of the clocks were trained to link age with methylation. The best clocks will deliver an estimate that reflects how far a person’s biology deviates from the average. Aging clocks are still judged on how well they can predict a person’s chronological age, but you don’t want them to be too close, says Lucas Paulo de Lima Camillo, head of machine learning at Shift Bioscience, who was awarded $10,000 by the Biomarkers of Aging Consortium for developing a clock that could estimate age within a range of 2.55 years. None of the clocks are precise enough to predict the biological age of a single person. Putting the same biological sample through five different clocks will give you five wildly different results.LEON EDLER “There’s this paradox,” says Camillo. If a clock is really good at predicting chronological age, that’s all it will tell you—and it probably won’t reveal much about your biological age. No one needs an aging clock to tell them how many birthdays they’ve had. Camillo says he’s noticed that when the clocks get too close to “perfect” age prediction, they actually become less accurate at predicting mortality. Therein lies the other central issue for scientists who develop and use aging clocks: What is the thing they are really measuring? It is a difficult question for a field whose members notoriously fail to agree on the basics. (Everything from the definition of aging to how it occurs and why is up for debate among the experts.) They do agree that aging is incredibly complex. A methylation-based aging clock might tell you about how that collection of chemical markers compares across individuals, but at best, it’s only giving you an idea of their “epigenetic age,” says Chandra. There are probably plenty of other biological markers that might reveal other aspects of aging, he says: “None of the clocks measure everything.”  We don’t know why some methyl groups appear or disappear with age, either. Are these changes causing damage? Or are they a by-product of it? Are the epigenetic patterns seen in a 90-year-old a sign of deterioration? Or have they been responsible for keeping that person alive into very old age? To make matters even more complicated, two different clocks can give similar answers by measuring methylation at entirely different regions of the genome. No one knows why, or which regions might be the best ones to focus on. “The biomarkers have this black-box quality,” says Jesse Poganik at Brigham and Women’s Hospital in Boston. “Some of them are probably causal, some of them may be adaptive … and some of them may just be neutral”: either “there’s no reason for them not to happen” or “they just happen by random chance.” What we know is that, as things stand, none of the clocks are precise enough to predict the biological age of a single person (sorry, Khloé). Putting the same biological sample through five different clocks will give you five wildly different results. Even the same clock can give you different answers if you put a sample through it more than once. “They’re not yet individually predictive,” says Herzog. “We don’t know what [a clock result] means for a person, [or if] they’re more or less likely to develop disease.” And it’s why plenty of aging researchers—even those who regularly use the clocks in their work—haven’t bothered to measure their own epigenetic age. “Let’s say I do a clock and it says that my biological age … is five years older than it should be,” says Magalhães. “So what?” He shrugs. “I don’t see much point in it.” You might think this lack of clarity would make aging clocks pretty useless in a clinical setting. But plenty of clinics are offering them anyway. Some longevity clinics are more careful, and will regularly test their patients with a range of clocks, noting their results and tracking them over time. Others will simply offer an estimate of biological age as part of a longevity treatment package. And then there are the people who use aging clocks to sell supplements. While no drug or supplement has been definitively shown to make people live longer, that hasn’t stopped the lightly regulated wellness industry from pushing a range of “treatments” that range from lotions to herbal pills all the way through to stem-cell injections. Some of these people come to aging meetings. I was in the audience at an event when one CEO took to the stage to claim he had reversed his own biological age by 18 years—thanks to the supplement he was selling. Tom Weldon of Ponce de Leon Health told us his gray hair was turning brown. His biological age was supposedly reversing so rapidly that he had reached “longevity escape velocity.” But if the people who buy his supplements expect some kind of Benjamin Button effect, they might be disappointed. His company hasn’t yet conducted a randomized controlled trial to demonstrate any anti-aging effects of that supplement, called Rejuvant. Weldon says that such a trial would take years and cost millions of dollars, and that he’d “have to increase the price of our product more than four times” to pay for one. (The company has so far tested the active ingredient in mice and carried out a provisional trial in people.) More generally, Horvath says he “gets a bad taste in [his] mouth” when people use the clocks to sell products and “make a quick buck.” But he thinks that most of those sellers have genuine faith in both the clocks and their products. “People truly believe their own nonsense,” he says. “They are so passionate about what they discovered, they fall into this trap of believing [their] own prejudices.”  The accuracy of the clocks is at a level that makes them useful for research, but not for individual predictions. Even if a clock did tell someone they were five years younger than their chronological age, that wouldn’t necessarily mean the person could expect to live five years longer, says Magalhães. “The field of aging has long been a rich ground for snake-oil salesmen and hype,” he says. “It comes with the territory.” (Weldon, for his part, says Rejuvant is the only product that has “clinically meaningful” claims.)  In any case, Magalhães adds that he thinks any publicity is better than no publicity. And there’s the rub. Most people in the longevity field seem to have mixed feelings about the trendiness of aging clocks and how they are being used. They’ll agree that the clocks aren’t ready for consumer prime time, but they tend to appreciate the attention. Longevity research is expensive, after all. With a surge in funding and an explosion in the number of biotech companies working on longevity, aging scientists are hopeful that innovation and progress will follow.  So they want to be sure that the reputation of aging clocks doesn’t end up being tarnished by association. Because while influencers and supplement sellers are using their “biological ages” to garner attention, scientists are now using these clocks to make some remarkable discoveries. Discoveries that are changing the way we think about aging. How to be young again Two little mice lie side by side, anesthetized and unconscious, as Jim White prepares his scalpel. The animals are of the same breed but look decidedly different. One is a youthful three-month-old, its fur thick, black, and glossy. By comparison, the second mouse, a 20-month-old, looks a little the worse for wear. Its fur is graying and patchy. Its whiskers are short, and it generally looks kind of frail. But the two mice are about to have a lot more in common. White, with some help from a colleague, makes incisions along the side of each mouse’s body and into the upper part of an arm and leg on the same side. He then carefully stitches the two animals together—membranes, fascia, and skin.  The procedure takes around an hour, and the mice are then roused from their anesthesia. At first, the two still-groggy animals pull away from each other. But within a few days, they seem to have accepted that they now share their bodies. Soon their circulatory systems will fuse, and the animals will share a blood flow too. “People are complicated. There’s a huge error bar.” — Steve Horvath, former biostatistician at the University of California, Los AngelesLEON EDLER White, who studies aging at Duke University, has been stitching mice together for years; he has performed this strange procedure, known as heterochronic parabiosis, more than a hundred times. And he’s seen a curious phenomenon occur. The older mice appear to benefit from the arrangement. They seem to get younger. Experiments with heterochronic parabiosis have been performed for decades, but typically scientists keep the mice attached to each other for only a few weeks, says White. In their experiment, he and his colleagues left the mice attached for three months—equivalent to around 10 human years. The team then carefully separated the animals to assess how each of them had fared. “You’d think that they’d want to separate immediately,” says White. “But when you detach them … they kind of follow each other around.” The most striking result of that experiment was that the older mice who had been attached to a younger mouse ended up living longer than other mice of a similar age. “[They lived] around 10% longer, but [they] also maintained a lot of [their] function,” says White. They were more active and maintained their strength for longer, he adds. When his colleagues, including Poganik, applied aging clocks to the mice, they found that their epigenetic ages were lower than expected. “The young circulation slowed aging in the old mice,” says White. The effect seemed to last, too—at least for a little while. “It preserved that youthful state for longer than we expected,” he says. The young mice went the other way and appeared biologically older, both while they were attached to the old mice and shortly after they were detached. But in their case, the effect seemed to be short-lived, says White: “The young mice went back to being young again.”  To White, this suggests that something about the “youthful state” might be programmed in some way. That perhaps it is written into our DNA. Maybe we don’t have to go through the biological process of aging.  This gets at a central debate in the aging field: What is aging, and why does it happen? Some believe it’s simply a result of accumulated damage. Some believe that the aging process is programmed; just as we grow limbs, develop a brain, reach puberty, and experience menopause, we are destined to deteriorate. Others think programs that play an important role in our early development just turn out to be harmful later in life by chance. And there are some scientists who agree with all of the above. White’s theory is that being old is just “a loss of youth,” he says. If that’s the case, there’s a silver lining: Knowing how youth is lost might point toward a way to somehow regain it, perhaps by restoring those youthful programs in some way.  Dogs and dolphins Horvath’s eponymous clock was developed by measuring methylation in DNA samples taken from tissues around the body. It seems to represent aging in all these tissues, which is why Horvath calls it a pan-tissue clock. Given that our organs are thought to age differently, it was remarkable that a single clock could measure aging in so many of them. But Horvath had ambitious plans for an even more universal clock: a pan-species model that could measure aging in all mammals. He started out, in 2017, with an email campaign that involved asking hundreds of scientists around the world to share samples of tissues from animals they had worked with. He tried zoos, too.    The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it. “I learned that people had spent careers collecting [animal] tissues,” he says. “They had freezers full of [them].” Amenable scientists would ship those frozen tissues, or just DNA, to Horvath’s lab in California, where he would use them to train a new model. Horvath says he initially set out to profile 30 different species. But he ended up receiving around 15,000 samples from 200 scientists, representing 348 species—including everything from dogs to dolphins. Could a single clock really predict age in all of them? “I truly felt it would fail,” says Horvath. “But it turned out that I was completely wrong.” He and his colleagues developed a clock that assessed methylation at 36,000 locations on the genome. The result, which was published in 2023 as the pan-mammalian clock, can estimate the age of any mammal and even the maximum lifespan of the species. The data set is open to anyone who wants to download it, he adds: “I hope people will mine the data to find the secret of how to extend a healthy lifespan.” The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it. Comparisons between mammals also support the idea that the slower methylation changes occur, the longer the lifespan of the animal, says Nelly Olova, an epigeneticist who researches aging at the University of Edinburgh in the UK. “DNA methylation slowly erodes with age,” she says. “We still have the instructions in place, but they become a little messier.” The research in different mammals suggests that cells can take only so much change before they stop functioning. “There’s a finite amount of change that the cell can tolerate,” she says. “If the instructions become too messy and noisy … it cannot support life.” Olova has been investigating exactly when aging clocks first begin to tick—in other words, the point at which aging starts. Clocks can be trained on data from volunteers, and by matching the patterns of methylation on their DNA to their chronological age. The trained clocks are then typically used to estimate the biological age of adults. But they can also be used on samples from children. Or babies. They can be used to work out the biological age of cells that make up embryos.  In her research, Olova used adult skin cells, which—thanks to Nobel Prize–winning research in the 2000s—can be “reprogrammed” back to a state resembling that of the pluripotent stem cells found in embryos. When Olova and her colleagues used a “partial reprogramming” approach to take cells close to that state, they found that the closer they got to the entirely reprogrammed state, the “younger” the cells were.  It was around 20 days after the cells had been reprogrammed into stem cells that they reached the biological age of zero according to the clock used, says Olova. “It was a bit surreal,” she says. “The pluripotent cells measure as minus 0.5; they’re slightly below zero.” Vadim Gladyshev, a prominent aging researcher at Harvard University, has since proposed that the same negative level of aging might apply to embryos. After all, some kind of rejuvenation happens during the early stages of embryo formation—an aged egg cell and an aged sperm cell somehow create a brand-new cell. The slate is wiped clean. Gladyshev calls this point “ground zero.” He posits that it’s reached sometime during the “mid-embryonic state.” At this point, aging begins. And so does “organismal life,” he argues. “It’s interesting how this coincides with philosophical questions about when life starts,” says Olova.  Some have argued that life begins when sperm meets egg, while others have suggested that the point when embryonic cells start to form some kind of unified structure is what counts. The ground zero point is when the body plan is set out and cells begin to organize accordingly, she says. “Before that, it’s just a bunch of cells.” This doesn’t mean that life begins at the embryonic state, but it does suggest that this is when aging begins—perhaps as the result of “a generational clearance of damage,” says Poganik. It is early days—no pun intended—for this research, and the science is far from settled. But knowing when aging begins could help inform attempts to rewind the clock. If scientists can pinpoint an ideal biological age for cells, perhaps they can find ways to get old cells back to that state. There might be a way to slow aging once cells reach a certain biological age, too.  “Presumably, there may be opportunities for targeting aging before … you’re full of gray hair,” says Poganik. “It could mean that there is an ideal window for intervention which is much earlier than our current geriatrics-based approach.” When young meets old When White first started stitching mice together, he would sit and watch them for hours. “I was like, look at them go! They’re together, and they don’t even care!” he says. Since then, he’s learned a few tricks. He tends to work with female mice, for instance—the males tend to bicker and nip at each other, he says. The females, on the other hand, seem to get on well.  The effect their partnership appears to have on their biological ages, if only temporarily, is among the ways aging clocks are helping us understand that biological age is plastic to some degree. White and his colleagues have also found, for instance, that stress seems to increase biological age, but that the effect can be reversed once the stress stops. Both pregnancy and covid-19 infections have a similar reversible effect. Poganik wonders if this finding might have applications for human organ transplants. Perhaps there’s a way to measure the biological age of an organ before it is transplanted and somehow rejuvenate organs before surgery.  But new data from aging clocks suggests that this might be more complicated than it sounds. Poganik and his colleagues have been using methylation clocks to measure the biological age of samples taken from recently transplanted hearts in living people.  If being old is simply a case of losing our youthfulness, then that might give us a clue to how we can somehow regain it. Young hearts do well in older bodies, but the biological age of these organs eventually creeps up to match that of their recipient. The same is true for older hearts in younger bodies, says Poganik, who has not yet published his findings. “After a few months, the tissue may assimilate the biological age of the organism,” he says.  If that’s the case, the benefits of young organs might be short-lived. It also suggests that scientists working on ways to rejuvenate individual organs may need to focus their anti-aging efforts on more systemic means of rejuvenation—for example, stem cells that repopulate the blood. Reprogramming these cells to a youthful state, perhaps one a little closer to “ground zero,” might be the way to go. Whole-body rejuvenation might be some way off, but scientists are still hopeful that aging clocks might help them find a way to reverse aging in people. “We have the machinery to reset our epigenetic clock to a more youthful state,” says White. “That means we have the ability to turn the clock backwards.” 

Be honest: Have you ever looked up someone from your childhood on social media with the sole intention of seeing how they’ve aged? 

One of my colleagues, who shall remain nameless, certainly has. He recently shared a photo of a former classmate. “Can you believe we’re the same age?” he asked, with a hint of glee in his voice. A relative also delights in this pastime. “Wow, she looks like an old woman,” she’ll say when looking at a picture of someone she has known since childhood. The years certainly are kinder to some of us than others.

But wrinkles and gray hairs aside, it can be difficult to know how well—or poorly—someone’s body is truly aging, under the hood. A person who develops age-related diseases earlier in life, or has other biological changes associated with aging (such as elevated cholesterol or markers of inflammation), might be considered “biologically older” than a similar-age person who doesn’t have those changes. Some 80-year-olds will be weak and frail, while others are fit and active. 

Doctors have long used functional tests that measure their patients’ strength or the distance they can walk, for example, or simply “eyeball” them to guess whether they look fit enough to survive some treatment regimen, says Tamir Chandra, who studies aging at the Mayo Clinic. 

But over the past decade, scientists have been uncovering new methods of looking at the hidden ways our bodies are aging. What they’ve found is changing our understanding of aging itself. 

“Aging clocks” are new scientific tools that can measure how our organs are wearing out, giving us insight into our mortality and health. They hint at our biological age. While chronological age is simply how many birthdays we’ve had, biological age is meant to reflect something deeper. It measures how our bodies are handling the passing of time and—perhaps—lets us know how much more of it we have left. And while you can’t change your chronological age, you just might be able to influence your biological age.

It’s not just scientists who are using these clocks. Longevity influencers like Bryan Johnson often use them to make the case that they are aging backwards. “My telomeres say I’m 10 years old,” Johnson posted on X in April. The Kardashians have tried them too (Khloé was told on TV that her biological age was 12 years below her chronological age). Even my local health-food store offers biological age testing. Some are pushing the use of clocks even further, using them to sell unproven “anti-aging” supplements.

The science is still new, and few experts in the field—some of whom affectionately refer to it as “clock world”—would argue that an aging clock can definitively reveal an individual’s biological age. 

But their work is revealing that aging clocks can offer so much more than an insta-brag, a snake-oil pitch—or even just an eye-catching number. In fact, they are helping scientists unravel some of the deepest mysteries in biology: Why do we age? How do we age? When does aging begin? What does it even mean to age?

Ultimately, and most importantly, they might soon tell us whether we can reverse the whole process.

Clocks kick off

The way your genes work can change. Molecules called methyl groups can attach to DNA, controlling the way genes make proteins. This process is called methylation, and it can potentially occur at millions of points along the genome. These epigenetic markers, as they are known, can switch genes on or off, or increase or decrease how much protein they make. They’re not part of our DNA, but they influence how it works.

In 2011, Steve Horvath, then a biostatistician at the University of California, Los Angeles, took part in a study that was looking for links between sexual orientation and these epigenetic markers. Steve is straight; he says his twin brother, Markus, who also volunteered, is gay.

That study didn’t find a link between DNA methyl­ation and sexual orientation. But when Horvath looked at the data, he noticed a different trend—a very strong link between age and methylation at around 88 points on the genome. He once told me he fell off his chair when he saw it

Many of the affected genes had already been linked to age-related brain and cardiovascular diseases, but it wasn’t clear how methylation might be related to those diseases. 

If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all.

In 2013, Horvath collected methylation data from 8,000 tissue and cell samples to create what he called the Horvath clock—essentially a mathematical model that could estimate age on the basis of DNA methylation at 353 points on the genome. From a tissue sample, it was able to detect a person’s age within a range of 2.9 years.

That clock changed everything. Its publication in 2013 marked the birth of “clock world.” To some, the possibilities were almost endless. If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all.

The epigenetic clock was a success story in “a field that, frankly, doesn’t have a lot of success stories,” says João Pedro de Magalhães, who researches aging at the University of Birmingham, UK.

It took a few years, but as more aging researchers heard about the clock, they began incorporating it into their research and even developing their own clocks. Horvath became a bit of a celebrity. Scientists started asking for selfies with him at conferences, he says. Some researchers even made T-shirts bearing the front page of his 2013 paper.

Some of the many other aging clocks developed since have become notable in their own right. Examples include the PhenoAge clock, which incorporates health data such as blood cell counts and signs of inflammation along with methyl­ation, and the Dunedin Pace of Aging clock, which tells you how quickly or slowly a person is aging rather than pointing to a specific age. Many of the clocks measure methylation, but some look at other variables, such as proteins in blood or certain carbohydrate molecules that attach to such proteins.

Today, there are hundreds or even thousands of clocks out there, says Chiara Herzog, who researches aging at King’s College London and is a member of the Biomarkers of Aging Consortium. Everyone has a favorite. Horvath himself favors his GrimAge clock, which was named after the Grim Reaper because it is designed to predict time to death.

That clock was trained on data collected from people who were monitored for decades, many of whom died in that period. Horvath won’t use it to tell people when they might die of old age, he stresses, saying that it wouldn’t be ethical. Instead, it can be used to deliver a biological age that hints at how long a person might expect to live. Someone who is 50 but has a GrimAge of 60 can assume that, compared with the average 50-year-old, they might be a bit closer to the end.

GrimAge is not perfect. While it can strongly predict time to death given the health trajectory someone is on, no aging clock can predict if someone will start smoking or get a divorce (which generally speeds aging) or suddenly take up running (which can generally slow it). “People are complicated,” Horvath tells MIT Technology Review. “There’s a huge error bar.”

On the whole, the clocks are pretty good at making predictions about health and lifespan. They’ve been able to predict that people over the age of 105 have lower biological ages, which tracks given how rare it is for people to make it past that age. A higher epigenetic age has been linked to declining cognitive function and signs of Alzheimer’s disease, while better physical and cognitive fitness has been linked to a lower epigenetic age.

Black-box clocks

But accuracy is a challenge for all aging clocks. Part of the problem lies in how they were designed. Most of the clocks were trained to link age with methylation. The best clocks will deliver an estimate that reflects how far a person’s biology deviates from the average. Aging clocks are still judged on how well they can predict a person’s chronological age, but you don’t want them to be too close, says Lucas Paulo de Lima Camillo, head of machine learning at Shift Bioscience, who was awarded $10,000 by the Biomarkers of Aging Consortium for developing a clock that could estimate age within a range of 2.55 years.

a cartoon alarm clock shrugging
None of the clocks are precise enough to predict the biological age of a single person. Putting the same biological sample through five different clocks will give you five wildly different results.
LEON EDLER

“There’s this paradox,” says Camillo. If a clock is really good at predicting chronological age, that’s all it will tell you—and it probably won’t reveal much about your biological age. No one needs an aging clock to tell them how many birthdays they’ve had. Camillo says he’s noticed that when the clocks get too close to “perfect” age prediction, they actually become less accurate at predicting mortality.

Therein lies the other central issue for scientists who develop and use aging clocks: What is the thing they are really measuring? It is a difficult question for a field whose members notoriously fail to agree on the basics. (Everything from the definition of aging to how it occurs and why is up for debate among the experts.)

They do agree that aging is incredibly complex. A methylation-based aging clock might tell you about how that collection of chemical markers compares across individuals, but at best, it’s only giving you an idea of their “epigenetic age,” says Chandra. There are probably plenty of other biological markers that might reveal other aspects of aging, he says: “None of the clocks measure everything.” 

We don’t know why some methyl groups appear or disappear with age, either. Are these changes causing damage? Or are they a by-product of it? Are the epigenetic patterns seen in a 90-year-old a sign of deterioration? Or have they been responsible for keeping that person alive into very old age?

To make matters even more complicated, two different clocks can give similar answers by measuring methylation at entirely different regions of the genome. No one knows why, or which regions might be the best ones to focus on.

“The biomarkers have this black-box quality,” says Jesse Poganik at Brigham and Women’s Hospital in Boston. “Some of them are probably causal, some of them may be adaptive … and some of them may just be neutral”: either “there’s no reason for them not to happen” or “they just happen by random chance.”

What we know is that, as things stand, none of the clocks are precise enough to predict the biological age of a single person (sorry, Khloé). Putting the same biological sample through five different clocks will give you five wildly different results.

Even the same clock can give you different answers if you put a sample through it more than once. “They’re not yet individually predictive,” says Herzog. “We don’t know what [a clock result] means for a person, [or if] they’re more or less likely to develop disease.”

And it’s why plenty of aging researchers—even those who regularly use the clocks in their work—haven’t bothered to measure their own epigenetic age. “Let’s say I do a clock and it says that my biological age … is five years older than it should be,” says Magalhães. “So what?” He shrugs. “I don’t see much point in it.”

You might think this lack of clarity would make aging clocks pretty useless in a clinical setting. But plenty of clinics are offering them anyway. Some longevity clinics are more careful, and will regularly test their patients with a range of clocks, noting their results and tracking them over time. Others will simply offer an estimate of biological age as part of a longevity treatment package.

And then there are the people who use aging clocks to sell supplements. While no drug or supplement has been definitively shown to make people live longer, that hasn’t stopped the lightly regulated wellness industry from pushing a range of “treatments” that range from lotions to herbal pills all the way through to stem-cell injections.

Some of these people come to aging meetings. I was in the audience at an event when one CEO took to the stage to claim he had reversed his own biological age by 18 years—thanks to the supplement he was selling. Tom Weldon of Ponce de Leon Health told us his gray hair was turning brown. His biological age was supposedly reversing so rapidly that he had reached “longevity escape velocity.”

But if the people who buy his supplements expect some kind of Benjamin Button effect, they might be disappointed. His company hasn’t yet conducted a randomized controlled trial to demonstrate any anti-aging effects of that supplement, called Rejuvant. Weldon says that such a trial would take years and cost millions of dollars, and that he’d “have to increase the price of our product more than four times” to pay for one. (The company has so far tested the active ingredient in mice and carried out a provisional trial in people.)

More generally, Horvath says he “gets a bad taste in [his] mouth” when people use the clocks to sell products and “make a quick buck.” But he thinks that most of those sellers have genuine faith in both the clocks and their products. “People truly believe their own nonsense,” he says. “They are so passionate about what they discovered, they fall into this trap of believing [their] own prejudices.” 

The accuracy of the clocks is at a level that makes them useful for research, but not for individual predictions. Even if a clock did tell someone they were five years younger than their chronological age, that wouldn’t necessarily mean the person could expect to live five years longer, says Magalhães. “The field of aging has long been a rich ground for snake-oil salesmen and hype,” he says. “It comes with the territory.” (Weldon, for his part, says Rejuvant is the only product that has “clinically meaningful” claims.) 

In any case, Magalhães adds that he thinks any publicity is better than no publicity.

And there’s the rub. Most people in the longevity field seem to have mixed feelings about the trendiness of aging clocks and how they are being used. They’ll agree that the clocks aren’t ready for consumer prime time, but they tend to appreciate the attention. Longevity research is expensive, after all. With a surge in funding and an explosion in the number of biotech companies working on longevity, aging scientists are hopeful that innovation and progress will follow. 

So they want to be sure that the reputation of aging clocks doesn’t end up being tarnished by association. Because while influencers and supplement sellers are using their “biological ages” to garner attention, scientists are now using these clocks to make some remarkable discoveries. Discoveries that are changing the way we think about aging.

How to be young again

Two little mice lie side by side, anesthetized and unconscious, as Jim White prepares his scalpel. The animals are of the same breed but look decidedly different. One is a youthful three-month-old, its fur thick, black, and glossy. By comparison, the second mouse, a 20-month-old, looks a little the worse for wear. Its fur is graying and patchy. Its whiskers are short, and it generally looks kind of frail.

But the two mice are about to have a lot more in common. White, with some help from a colleague, makes incisions along the side of each mouse’s body and into the upper part of an arm and leg on the same side. He then carefully stitches the two animals together—membranes, fascia, and skin. 

The procedure takes around an hour, and the mice are then roused from their anesthesia. At first, the two still-groggy animals pull away from each other. But within a few days, they seem to have accepted that they now share their bodies. Soon their circulatory systems will fuse, and the animals will share a blood flow too.

cartoon man in profile with a stick of a wrist watch around a lit stick of dynamite in his mouth
“People are complicated. There’s a huge error bar.” — Steve Horvath, former biostatistician at the University of California, Los Angeles
LEON EDLER

White, who studies aging at Duke University, has been stitching mice together for years; he has performed this strange procedure, known as heterochronic parabiosis, more than a hundred times. And he’s seen a curious phenomenon occur. The older mice appear to benefit from the arrangement. They seem to get younger.

Experiments with heterochronic parabiosis have been performed for decades, but typically scientists keep the mice attached to each other for only a few weeks, says White. In their experiment, he and his colleagues left the mice attached for three months—equivalent to around 10 human years. The team then carefully separated the animals to assess how each of them had fared. “You’d think that they’d want to separate immediately,” says White. “But when you detach them … they kind of follow each other around.”

The most striking result of that experiment was that the older mice who had been attached to a younger mouse ended up living longer than other mice of a similar age. “[They lived] around 10% longer, but [they] also maintained a lot of [their] function,” says White. They were more active and maintained their strength for longer, he adds.

When his colleagues, including Poganik, applied aging clocks to the mice, they found that their epigenetic ages were lower than expected. “The young circulation slowed aging in the old mice,” says White. The effect seemed to last, too—at least for a little while. “It preserved that youthful state for longer than we expected,” he says.

The young mice went the other way and appeared biologically older, both while they were attached to the old mice and shortly after they were detached. But in their case, the effect seemed to be short-lived, says White: “The young mice went back to being young again.” 

To White, this suggests that something about the “youthful state” might be programmed in some way. That perhaps it is written into our DNA. Maybe we don’t have to go through the biological process of aging. 

This gets at a central debate in the aging field: What is aging, and why does it happen? Some believe it’s simply a result of accumulated damage. Some believe that the aging process is programmed; just as we grow limbs, develop a brain, reach puberty, and experience menopause, we are destined to deteriorate. Others think programs that play an important role in our early development just turn out to be harmful later in life by chance. And there are some scientists who agree with all of the above.

White’s theory is that being old is just “a loss of youth,” he says. If that’s the case, there’s a silver lining: Knowing how youth is lost might point toward a way to somehow regain it, perhaps by restoring those youthful programs in some way. 

Dogs and dolphins

Horvath’s eponymous clock was developed by measuring methylation in DNA samples taken from tissues around the body. It seems to represent aging in all these tissues, which is why Horvath calls it a pan-tissue clock. Given that our organs are thought to age differently, it was remarkable that a single clock could measure aging in so many of them.

But Horvath had ambitious plans for an even more universal clock: a pan-species model that could measure aging in all mammals. He started out, in 2017, with an email campaign that involved asking hundreds of scientists around the world to share samples of tissues from animals they had worked with. He tried zoos, too.   

The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it.

“I learned that people had spent careers collecting [animal] tissues,” he says. “They had freezers full of [them].” Amenable scientists would ship those frozen tissues, or just DNA, to Horvath’s lab in California, where he would use them to train a new model.

Horvath says he initially set out to profile 30 different species. But he ended up receiving around 15,000 samples from 200 scientists, representing 348 species—including everything from dogs to dolphins. Could a single clock really predict age in all of them?

“I truly felt it would fail,” says Horvath. “But it turned out that I was completely wrong.” He and his colleagues developed a clock that assessed methylation at 36,000 locations on the genome. The result, which was published in 2023 as the pan-mammalian clock, can estimate the age of any mammal and even the maximum lifespan of the species. The data set is open to anyone who wants to download it, he adds: “I hope people will mine the data to find the secret of how to extend a healthy lifespan.”

The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it.

Comparisons between mammals also support the idea that the slower methylation changes occur, the longer the lifespan of the animal, says Nelly Olova, an epigeneticist who researches aging at the University of Edinburgh in the UK. “DNA methylation slowly erodes with age,” she says. “We still have the instructions in place, but they become a little messier.” The research in different mammals suggests that cells can take only so much change before they stop functioning.

“There’s a finite amount of change that the cell can tolerate,” she says. “If the instructions become too messy and noisy … it cannot support life.”

Olova has been investigating exactly when aging clocks first begin to tick—in other words, the point at which aging starts. Clocks can be trained on data from volunteers, and by matching the patterns of methylation on their DNA to their chronological age. The trained clocks are then typically used to estimate the biological age of adults. But they can also be used on samples from children. Or babies. They can be used to work out the biological age of cells that make up embryos. 

In her research, Olova used adult skin cells, which—thanks to Nobel Prize–winning research in the 2000s—can be “reprogrammed” back to a state resembling that of the pluripotent stem cells found in embryos. When Olova and her colleagues used a “partial reprogramming” approach to take cells close to that state, they found that the closer they got to the entirely reprogrammed state, the “younger” the cells were. 

It was around 20 days after the cells had been reprogrammed into stem cells that they reached the biological age of zero according to the clock used, says Olova. “It was a bit surreal,” she says. “The pluripotent cells measure as minus 0.5; they’re slightly below zero.”

Vadim Gladyshev, a prominent aging researcher at Harvard University, has since proposed that the same negative level of aging might apply to embryos. After all, some kind of rejuvenation happens during the early stages of embryo formation—an aged egg cell and an aged sperm cell somehow create a brand-new cell. The slate is wiped clean.

Gladyshev calls this point “ground zero.” He posits that it’s reached sometime during the “mid-embryonic state.” At this point, aging begins. And so does “organismal life,” he argues. “It’s interesting how this coincides with philosophical questions about when life starts,” says Olova. 

Some have argued that life begins when sperm meets egg, while others have suggested that the point when embryonic cells start to form some kind of unified structure is what counts. The ground zero point is when the body plan is set out and cells begin to organize accordingly, she says. “Before that, it’s just a bunch of cells.”

This doesn’t mean that life begins at the embryonic state, but it does suggest that this is when aging begins—perhaps as the result of “a generational clearance of damage,” says Poganik.

It is early days—no pun intended—for this research, and the science is far from settled. But knowing when aging begins could help inform attempts to rewind the clock. If scientists can pinpoint an ideal biological age for cells, perhaps they can find ways to get old cells back to that state. There might be a way to slow aging once cells reach a certain biological age, too. 

“Presumably, there may be opportunities for targeting aging before … you’re full of gray hair,” says Poganik. “It could mean that there is an ideal window for intervention which is much earlier than our current geriatrics-based approach.”

When young meets old

When White first started stitching mice together, he would sit and watch them for hours. “I was like, look at them go! They’re together, and they don’t even care!” he says. Since then, he’s learned a few tricks. He tends to work with female mice, for instance—the males tend to bicker and nip at each other, he says. The females, on the other hand, seem to get on well. 

The effect their partnership appears to have on their biological ages, if only temporarily, is among the ways aging clocks are helping us understand that biological age is plastic to some degree. White and his colleagues have also found, for instance, that stress seems to increase biological age, but that the effect can be reversed once the stress stops. Both pregnancy and covid-19 infections have a similar reversible effect.

Poganik wonders if this finding might have applications for human organ transplants. Perhaps there’s a way to measure the biological age of an organ before it is transplanted and somehow rejuvenate organs before surgery. 

But new data from aging clocks suggests that this might be more complicated than it sounds. Poganik and his colleagues have been using methylation clocks to measure the biological age of samples taken from recently transplanted hearts in living people. 

If being old is simply a case of losing our youthfulness, then that might give us a clue to how we can somehow regain it.

Young hearts do well in older bodies, but the biological age of these organs eventually creeps up to match that of their recipient. The same is true for older hearts in younger bodies, says Poganik, who has not yet published his findings. “After a few months, the tissue may assimilate the biological age of the organism,” he says. 

If that’s the case, the benefits of young organs might be short-lived. It also suggests that scientists working on ways to rejuvenate individual organs may need to focus their anti-aging efforts on more systemic means of rejuvenation—for example, stem cells that repopulate the blood. Reprogramming these cells to a youthful state, perhaps one a little closer to “ground zero,” might be the way to go.

Whole-body rejuvenation might be some way off, but scientists are still hopeful that aging clocks might help them find a way to reverse aging in people.

“We have the machinery to reset our epigenetic clock to a more youthful state,” says White. “That means we have the ability to turn the clock backwards.” 

Shape
Shape
Stay Ahead

Explore More Insights

Stay ahead with more perspectives on cutting-edge power, infrastructure, energy,  bitcoin and AI solutions. Explore these articles to uncover strategies and insights shaping the future of industries.

Shape

DOE and SBA Launch SBIC-E Initiative to Unleash Private Capital for American Innovation and Small Businesses

WASHINGTON—The U.S. Department of Energy (DOE) and the U.S. Small Business Administration (SBA) today signed a Memorandum of Agreement establishing the Small Business Investment Company-Energy (SBIC-E) Initiative, a new strategic partnership advancing President Trump’s commitment to supporting America’s small businesses, strengthening domestic manufacturing and supply chains, and ensuring the United States leads in the technologies critical to our national and economic security. The new SBIC-E Initiative brings together DOE’s scientific and technical expertise with SBA’s proven Small Business Investment Company (SBIC) Program, which currently has $58 billion in combined portfolio value. Since 1958, the SBIC Program has invested $147 billion in American small businesses, and since 1995, SBIC-backed businesses have created or supported 10.6 million jobs. “America’s small businesses drive American innovation and affordable, reliable energy access,” said U.S. Secretary of Energy Chris Wright. “By partnering with the Small Business Administration, the Energy Department is committing to invest its resources in American small businesses that will create jobs, strengthen our domestic manufacturing base, and unleash American energy production.” Through DOE’s Office of Technology Commercialization (OTC), the Department will identify strategic technology priorities, provide technical and commercialization expertise, and help engage the investment community. SBA, through its Office of Investment and Innovation, will administer the initiative and encourage the formation and growth of investment funds focused on those priorities. SBIC-E adds another tool to that effort by connecting innovators with private capital to help promising technologies grow, scale, and build here at home. “President Trump is establishing American energy dominance, ending the Green New Scam, and putting our nations’ producers and innovators back in control at the dawn of a new era of energy reliability and abundance,” said SBA Administrator Kelly Loeffler. “Through this partnership, the SBA and Department of Energy are strengthening access to capital in the private sector to

Read More »

Energy Department Announces $500 Million Award to Revitalize American Steelmaking

WASHINGTON—The U.S. Department of Energy (DOE) today announced a $500 million award to support a $1 billion investment at Cleveland-Cliffs’ Middletown Works facility in Middletown, Ohio. Vice President JD Vance and U.S. Energy Secretary Chris Wright visited Middletown Works today to highlight the Trump Administration’s commitment to American steelworkers and the resurgence of American manufacturing. The investment will modernize American steelmaking, protect 2,300 American jobs, and strengthen the domestic steel supply chain. The project advances President Trump’s commitment to put American workers first, bring investment back to American communities, and strengthen the industries critical to America’s economic and national security. Cleveland-Cliffs determined that the business case for the original project scope no longer made sense given customers’ unwillingness to pay a “green premium” for steel. Working with DOE, Cleveland-Cliffs identified a viable alternative that will upgrade and improve the efficiency of the existing coal-fired blast furnace while also capturing and commercializing co-product blast furnace gas (BFG). “President Trump is rebuilding America’s industrial base,” said Secretary Wright. “This investment puts American workers and American manufacturing first. It will modernize one of our nation’s critical steelmaking facilities, protect thousands of jobs, and strengthen our domestic steel production—keeping Ohio at the heart of American manufacturing and strengthening our national security.” The investment will modernize critical steelmaking operations at Middletown Works by rebuilding and upgrading the plant’s main coal-fired ironmaking furnace, deploying AI to optimize furnace operations and improve energy efficiency, and building an on-site facility to convert steel mill process gases into electricity. Follow-on investments will turn industrial byproducts into materials for concrete used in regional infrastructure. “This landmark investment at Middletown Works will secure a reliable domestic supply of high-purity steel while protecting thousands of quality jobs in Ohio,” said Assistant Secretary of Energy Audrey Robertson. “DOE is proud to partner with Cleveland-Cliffs to reduce America’s dependence on foreign products

Read More »

Energy Secretary Keeps Critical Generation Available in Mid-Atlantic

WASHINGTON—U.S. Secretary of Energy Chris Wright today issued an emergency order to address critical grid reliability issues facing the Mid-Atlantic region of the United States. The emergency order directs PJM Interconnection L.L.C. (PJM), in coordination with Constellation Energy Corporation, to ensure Units 3 and 4 of the Eddystone Generating Station in Pennsylvania remain available to operate and to employ economic dispatch to minimize costs for the American people. The units were originally slated to shut down on May 31, 2025. “The energy sources that perform when you need them most are the most valuable,” Secretary Wright said. “During recent Mid-Atlantic heat waves, coal, natural gas, and nuclear kept the lights and air conditioners on. President Trump and the Energy Department are committed to keeping critical generation available when demand is highest, reducing the risk of blackouts and ensuring Americans have affordable, reliable, and secure power—regardless of whether the wind is blowing or the sun is shining.” As outlined in DOE’s Resource Adequacy Report, power outages could increase by 100 times in 2030 if the U.S. continues to take reliable power offline. This order is in effect beginning on August 23, 2026, through November 20, 2026.                                                                                             ###

Read More »

Energy Department Announces $500 Million to Secure America’s Critical Mineral and Battery Supply Chains

WASHINGTON—The U.S. Department of Energy’s (DOE) Office of Critical Minerals and Energy Innovation (CMEI) today announced $500 million for seven selected projects to expand critical mineral and material processing, battery manufacturing, and recycling capacity in the United States. In accordance with President Trump’s Executive Order, Unleashing American Energy, the selected projects advance the President’s agenda to strengthen America’s domestic critical minerals and materials supply chains, reduce reliance on foreign sources, bolster national security, and advance American energy dominance. “For too long, America has depended on foreign actors for critical materials essential to modern life that underpin our economy, energy security, and national security,” said U.S. Secretary of Energy Chris Wright. “President Trump is reversing that dependence by securing our critical supply chains, unleashing American industry, and bringing critical materials production and processing back to the United States.” “DOE is taking decisive action to secure the critical supply chains necessary to power our nation,” said Assistant Secretary of Energy Audrey Robertson. “These projects underscore DOE’s commitment to driving innovation, reducing reliance on foreign sources, and promoting American energy dominance.” This is the third round of funding from DOE’s Battery Materials Processing and Battery Manufacturing and Recycling programs, which support battery materials processing, recycling, and manufacturing projects. These include demonstration projects, construction of commercial-scale facilities, and retrofitting or retooling existing facilities.  Critical minerals and materials are essential to American industry, energy production, and national security. Expanding domestic capacity will help ensure the resources America needs are processed, manufactured, and recycled in the United States.  Information on the selected projects is available here and here.

Read More »

bp lets Shah Deniz compression automation contract

bp has let a contract to Emerson to deliver automation technologies for the Shah Deniz Compression project offshore Azerbaijan. Emerson will provide integrated control and safety systems aimed at enhancing production, safety, and reliability on the new offshore compression platform. The contract includes systems to provide process control, safety shutdown, fire and gas detection, and power management. Together, these systems deliver real-time visibility and remote control of critical operations, Emerson said. The $2.9 billion Shah Deniz Compression project, which includes an electrically powered, normally unattended offshore production platform, is a next stage development of the Caspian Sea Shah Deniz field. Designed to access low-pressure gas reserves and maximize overall recovery, the platform will be equipped with four 11 Mw compressors and serve as the central compression hub for gas from the Shah Deniz Alpha and Bravo platforms. The platform will operate remotely from bp’s onshore Sangachal terminal 55 km south of Baku. The project is expected to enable about 50 billion cu m of additional gas and about 25 million bbl of condensate production and export. Construction is scheduled to be completed in 2029, with first gas compression expected from the Shah Deniz Alpha platform in 2029 and from the Shah Deniz Bravo platform in 2030. The agreement follows a previous automation contract bp signed with Emerson for the Azeri Central East and Shah Deniz Stage 2 developments. bp is operator at Shah Deniz (29.99%) with partners Lukoil (19.99%), TPAO (19%), Cenub Qaz Dehlizi (16.02%), NICO (10%), and MVM (5%).

Read More »

Federal court voids Texas GulfLink license over agency’s ‘serious procedural errors’

The ruling voids the license, halting all construction or progress. Sentinel Midstream declined comment on the ruling and would not answer questions about the status of construction. GulfLink, sited about 30 miles offshore Freeport, Tex., is designed to export up to 1 million b/d via Very Large Crude Carriers (VLCCs) to the government of Japan and Freeport Commodities. The project involves a 44-mile, 42-in. OD pipeline and was scheduled to begin operations around 2028. The estimated $2.1 billion investment was funded as part of a broader trade agreement between the US and Japan. The legal battle stems from a specific rule in the Deepwater Port Act of 1974 that dictates that the federal government can only permit one crude oil deepwater port, including any supporting infrastructure, within a single designated “application area.” Because the competing SPOT project’s pipeline route physically overlaps and intersects GulfLink’s lines, the plaintiff—Citizens for Clean Air & Clean Water in Brazoria County (Better Brazoria), represented by Earthjustice—successfully argued that MARAD violated the “one port” rule when issuing GulfLink’s license in February. The three-judge panel found that MARAD “improperly drew” the map designing the project’s official boundaries to exclude the pipelines and approved two overlapping projects in the same zone instead of only licensing one. The court wrote that the scope of the error made vacatur, not the less serious remand without vacatur, the appropriate remedy. Vacatur deems the license invalid and is used when the court finds “serious procedural errors” that cannot be easily explained or fixed with minor changes. Remand without vacatur sends the decision back to the agency for corrections but leaves the current license in place in the meantime. SPOT project status The $2.5-3-billion SPOT project, developed by Enterprise Products Partners in partnership with Enbridge Inc., also lies about 30 miles from Freeport. Designed to handle VLCCs,

Read More »

IBM unveils dual-architecture processor to run Arm-native apps on Z mainframes

“These caches have enormously low latency, and that is one of the key reasons and key engineering choices to support the performance and scalability of enterprise workloads, very data-intensive workloads like databases and transactions,” Jacobi said. “In addition, we have an on-chip data processing unit for IO acceleration and dedicated AI accelerators as well as accelerators for data compression, cryptography and data sorting.” One of the biggest takeaways from this processor announcement is that the enormous catalog of software already built for Arm becomes accessible on a mainframe without anyone having to port it first, notes Matt Kimball, senior datacenter analyst at Moor Insights & Strategy, in a research note about the news. Still, “this is a 2027 conversation, and with no date, supported software list, or Arm licensing treatment, the work now is inventory and scenario planning rather than financial modeling,” Kimball wrote.

Read More »

PJM’s New Data Center Power Equation

PJM Interconnection has now filed one of the most consequential proposed changes yet in the relationship between data centers and the electric grid. Rather than simply treating a new hyperscale or AI facility like any other customer whose demand will be backed through regional capacity procurement, PJM is proposing a framework under which the largest new loads would need to be supported by new capacity, have their needs covered through the Reliability Backstop Procurement, or face potential curtailment when the regional power system is short of supply. The approach has been developing since PJM launched its Critical Issue Fast Path process for large loads in 2025, but it became substantially more concrete in late July and August 2026. PJM filed its proposed Reliability Backstop Procurement with FERC on July 31 and began accepting applications that day for its FERC-approved Expedited Interconnection Track. On Aug. 13, PJM filed its proposed Interim Resource Adequacy Service, or IRAS, along with the Large Load Registry that would support it. The immediate numbers explain the urgency. PJM’s July 2026 capacity auction for the 2028/2029 delivery year procured 138,318 MW of unforced capacity through the centralized auction. Even after including Fixed Resource Requirement resources, however, PJM came up 6,831 MW short of its reliability requirement. The auction cleared at the FERC-approved $325/MW-day price cap. It was the second consecutive auction in which the PJM region failed to procure its full reliability requirement, something that had not happened before these two auctions. That gap is occurring while demand continues to accelerate. PJM’s 2026 long-term forecast projects summer peak demand growing at an average 3.6% annually over the next decade, compared with just 0.3% in the comparable forecast issued in 2021. Summer peak demand is projected to rise by nearly 66 GW over 10 years. Data centers are

Read More »

Zayo, NVIDIA Build the Long-Haul Backbone for Distributed AI

The data center industry’s increasingly power-first approach to site selection has created a follow-on question: Once the megawatts are found, is there enough network infrastructure to make the site useful at AI scale? Zayo and NVIDIA are putting real infrastructure behind that question. Zayo said it is working with NVIDIA to expand network capacity supporting AI factories across North America, including an 8,000-route-mile program targeting some of the fastest-growing AI corridors in the United States. The project encompasses six new long-haul routes along with overbuilds of existing network across 10 high-demand corridors. The announcement arrives as AI data center development moves beyond the largest established hubs toward markets where power and land may be more readily available, but fiber capacity cannot necessarily be taken for granted. That geography is increasingly important. NVIDIA has separately developed “scale-across” networking technology designed to allow AI infrastructure distributed among different buildings — or even data centers separated by hundreds of kilometers — to operate as a more unified computing environment. Put together, the developments suggest that networking is becoming inseparable from the AI factory buildout itself. Power may determine where the next generation of AI infrastructure can be built. Fiber will increasingly determine how effectively those sites can participate in the larger AI ecosystem. Fiber Follows the Power Zayo CEO Steve Smith said AI demand is changing both where network infrastructure is needed and how aggressively capacity must be deployed ahead of development. “AI is fundamentally reshaping where and how network infrastructure needs to be built across the U.S.,” Smith said. The company’s 8,000-mile program is more nuanced than that top-line number might suggest. Zayo disclosed in April that the expansion includes approximately 3,000 route miles across six new long-haul routes, plus more than 5,000 route miles of overbuilds across 10 existing corridors. Zayo

Read More »

Southern’s 17 GW Pipeline Puts AI Power Demand Into Utility Math

The headline number from Southern Company’s latest earnings report is hard to miss: electricity use by data centers across the utility’s system increased 55% in the second quarter compared with a year earlier. But the more consequential numbers may be the ones sitting behind it. Southern now has more than 1.2 GW of operating data center load, up by more than 500 MW from a year ago. At the same time, its electric utilities have signed contracts and large-load agreements totaling more than 17 GW by the mid-2030s, with another 8 GW in late-stage development and a prospective pipeline of large industrial and data center projects exceeding 75 GW. That leaves an enormous gap between the data center megawatts consuming electricity today and the load Southern has contractually positioned itself to serve during the next decade. For the data center industry, that gap may be the most important part of Southern’s second-quarter story. It offers a look at how utilities are beginning to convert the AI infrastructure boom from forecasts and campus announcements into contracts, generation procurement, transmission investment and eventually energized capacity. From Contracts to Megawatts Southern added roughly 6 GW of contracted large load during the quarter alone. Alabama Power signed three projects representing about 3 GW, while Georgia Power reached a 25-year agreement to serve OpenAI’s planned project in Effingham County near Savannah. That facility is expected to require approximately 3.2 GW and begin taking electric service in phases in 2028. The numbers nevertheless require an important distinction. Seventeen gigawatts contracted does not mean 17 GW will suddenly appear on Southern’s grid. Large data center campuses ramp gradually, often over several years, and Southern executives acknowledged that actual customer ramp schedules do not always match the assumptions made when projects are first approved. CEO Chris Womack said

Read More »

PORTS-Pike Takes Shape as an 8-GW AI Infrastructure Model

Back on March 31, 2026, we discussed we discussed SoftBank and SB Energy’s plans to redevelop the former Portsmouth Gaseous Diffusion Plant site near Piketon as a 10-GW artificial intelligence data center campus supported by almost an equal amount of new power generation. At the time, the plan called for as much as 10 GW of new generation, including 9.2 GW of natural gas capacity, along with approximately $4.2 billion of high-voltage transmission infrastructure developed with AEP Ohio. An initial 800-MW data center phase was targeted for service in 2028. The March story was notable because Pike County appeared to offer a preview of a new model for building hyperscale infrastructure: develop the generation, transmission and data center simultaneously rather than wait for an increasingly congested regional grid to deliver multiple gigawatts of capacity. Not to mention the reuse of a brownfield site with the encouragement of the federal government. Since then, almost every important part of the project has moved forward, and on August 17, the most consequential missing pieces fell into place. NVIDIA announced that it will become the exclusive AI compute infrastructure provider for the PORTS-Pike Technology Campus. OpenAI will be the data center customer, signing a 20-year lease with SB Energy for approximately 8 GW of IT capacity. NVIDIA will invest another $1.5 billion in SB Energy and provide credit support for the land, power and shell infrastructure behind an initial 4.25 GW of IT load, with an option covering approximately another 3.75 GW. The Securities and Exchange Commission filing accompanying the announcement makes the financial commitment even more significant. NVIDIA disclosed that its aggregate payment obligation associated with its initial commitment is capped at $105 billion. That is not a conventional capital commitment to spend $105 billion building the campus, nor is it simply a

Read More »

Nvidia scales back financing guarantee for OpenAI data center

Nvidia is scaling back a proposed financial guarantee tied to a massive OpenAI data center project in Ohio, reducing its initial commitment from as much as $250 billion to less than $120 billion, according to report in the Wall Street Journal. Earlier this month, Nvidia announced partnerships with major financial firms including Apollo Global Management, BlackRock, Blackstone, Brookfield Asset Management, Goldman Sachs and KKR, aimed at mobilizing more than $500 billion in capital for AI computing infrastructure. The change represents a significant restructuring of Nvidia’s role in financing the planned facility, which is being developed by SB Energy, a subsidiary of SoftBank. Under the revised arrangement, Nvidia would guarantee financing for the project’s first phase, representing roughly 5 gigawatts of capacity, or half of the total proposed capacity. Financing for the remaining capacity would be considered separately at a later stage.

Read More »

Microsoft will invest $80B in AI data centers in fiscal 2025

And Microsoft isn’t the only one that is ramping up its investments into AI-enabled data centers. Rival cloud service providers are all investing in either upgrading or opening new data centers to capture a larger chunk of business from developers and users of large language models (LLMs).  In a report published in October 2024, Bloomberg Intelligence estimated that demand for generative AI would push Microsoft, AWS, Google, Oracle, Meta, and Apple would between them devote $200 billion to capex in 2025, up from $110 billion in 2023. Microsoft is one of the biggest spenders, followed closely by Google and AWS, Bloomberg Intelligence said. Its estimate of Microsoft’s capital spending on AI, at $62.4 billion for calendar 2025, is lower than Smith’s claim that the company will invest $80 billion in the fiscal year to June 30, 2025. Both figures, though, are way higher than Microsoft’s 2020 capital expenditure of “just” $17.6 billion. The majority of the increased spending is tied to cloud services and the expansion of AI infrastructure needed to provide compute capacity for OpenAI workloads. Separately, last October Amazon CEO Andy Jassy said his company planned total capex spend of $75 billion in 2024 and even more in 2025, with much of it going to AWS, its cloud computing division.

Read More »

John Deere unveils more autonomous farm machines to address skill labor shortage

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Self-driving tractors might be the path to self-driving cars. John Deere has revealed a new line of autonomous machines and tech across agriculture, construction and commercial landscaping. The Moline, Illinois-based John Deere has been in business for 187 years, yet it’s been a regular as a non-tech company showing off technology at the big tech trade show in Las Vegas and is back at CES 2025 with more autonomous tractors and other vehicles. This is not something we usually cover, but John Deere has a lot of data that is interesting in the big picture of tech. The message from the company is that there aren’t enough skilled farm laborers to do the work that its customers need. It’s been a challenge for most of the last two decades, said Jahmy Hindman, CTO at John Deere, in a briefing. Much of the tech will come this fall and after that. He noted that the average farmer in the U.S. is over 58 and works 12 to 18 hours a day to grow food for us. And he said the American Farm Bureau Federation estimates there are roughly 2.4 million farm jobs that need to be filled annually; and the agricultural work force continues to shrink. (This is my hint to the anti-immigration crowd). John Deere’s autonomous 9RX Tractor. Farmers can oversee it using an app. While each of these industries experiences their own set of challenges, a commonality across all is skilled labor availability. In construction, about 80% percent of contractors struggle to find skilled labor. And in commercial landscaping, 86% of landscaping business owners can’t find labor to fill open positions, he said. “They have to figure out how to do

Read More »

2025 playbook for enterprise AI success, from agents to evals

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More 2025 is poised to be a pivotal year for enterprise AI. The past year has seen rapid innovation, and this year will see the same. This has made it more critical than ever to revisit your AI strategy to stay competitive and create value for your customers. From scaling AI agents to optimizing costs, here are the five critical areas enterprises should prioritize for their AI strategy this year. 1. Agents: the next generation of automation AI agents are no longer theoretical. In 2025, they’re indispensable tools for enterprises looking to streamline operations and enhance customer interactions. Unlike traditional software, agents powered by large language models (LLMs) can make nuanced decisions, navigate complex multi-step tasks, and integrate seamlessly with tools and APIs. At the start of 2024, agents were not ready for prime time, making frustrating mistakes like hallucinating URLs. They started getting better as frontier large language models themselves improved. “Let me put it this way,” said Sam Witteveen, cofounder of Red Dragon, a company that develops agents for companies, and that recently reviewed the 48 agents it built last year. “Interestingly, the ones that we built at the start of the year, a lot of those worked way better at the end of the year just because the models got better.” Witteveen shared this in the video podcast we filmed to discuss these five big trends in detail. Models are getting better and hallucinating less, and they’re also being trained to do agentic tasks. Another feature that the model providers are researching is a way to use the LLM as a judge, and as models get cheaper (something we’ll cover below), companies can use three or more models to

Read More »

OpenAI’s red teaming innovations define new essentials for security leaders in the AI era

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More OpenAI has taken a more aggressive approach to red teaming than its AI competitors, demonstrating its security teams’ advanced capabilities in two areas: multi-step reinforcement and external red teaming. OpenAI recently released two papers that set a new competitive standard for improving the quality, reliability and safety of AI models in these two techniques and more. The first paper, “OpenAI’s Approach to External Red Teaming for AI Models and Systems,” reports that specialized teams outside the company have proven effective in uncovering vulnerabilities that might otherwise have made it into a released model because in-house testing techniques may have missed them. In the second paper, “Diverse and Effective Red Teaming with Auto-Generated Rewards and Multi-Step Reinforcement Learning,” OpenAI introduces an automated framework that relies on iterative reinforcement learning to generate a broad spectrum of novel, wide-ranging attacks. Going all-in on red teaming pays practical, competitive dividends It’s encouraging to see competitive intensity in red teaming growing among AI companies. When Anthropic released its AI red team guidelines in June of last year, it joined AI providers including Google, Microsoft, Nvidia, OpenAI, and even the U.S.’s National Institute of Standards and Technology (NIST), which all had released red teaming frameworks. Investing heavily in red teaming yields tangible benefits for security leaders in any organization. OpenAI’s paper on external red teaming provides a detailed analysis of how the company strives to create specialized external teams that include cybersecurity and subject matter experts. The goal is to see if knowledgeable external teams can defeat models’ security perimeters and find gaps in their security, biases and controls that prompt-based testing couldn’t find. What makes OpenAI’s recent papers noteworthy is how well they define using human-in-the-middle

Read More »